Does ALEMTUZUMAB Cause Lymphocyte count decreased? 852 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 852 reports of Lymphocyte count decreased have been filed in association with ALEMTUZUMAB (Campath). This represents 6.0% of all adverse event reports for ALEMTUZUMAB.
852
Reports of Lymphocyte count decreased with ALEMTUZUMAB
6.0%
of all ALEMTUZUMAB reports
15
Deaths
259
Hospitalizations
How Dangerous Is Lymphocyte count decreased From ALEMTUZUMAB?
Of the 852 reports, 15 (1.8%) resulted in death, 259 (30.4%) required hospitalization, and 25 (2.9%) were considered life-threatening.
Is Lymphocyte count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 852 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Asthenia (841)
Multiple sclerosis relapse (836)
Urinary tract infection (746)
What Other Drugs Cause Lymphocyte count decreased?
FINGOLIMOD (3,232)
DIMETHYL (960)
CLOZAPINE (731)
RITUXIMAB (633)
CYCLOPHOSPHAMIDE (541)
METHYLPREDNISOLONE (532)
CLADRIBINE (448)
DEXAMETHASONE (423)
PREDNISONE (399)
SIPONIMOD (398)
Which ALEMTUZUMAB Alternatives Have Lower Lymphocyte count decreased Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET